46 results
8-K
EX-1.1
TRML
Tourmaline Bio Inc
26 Jan 24
Other Events
4:12pm
Assets Control of the U.S. Department of the Treasury (“OFAC”) or the U.S. Department of State, the United Nations Security Council, the European Union … subsidiaries have made all such filings and obtained all such approvals as may be required by the Food and Drug Administration of the U.S. Department
424B5
TRML
Tourmaline Bio Inc
26 Jan 24
Prospectus supplement for primary offering
4:08pm
institution and is subject to the diligence and reporting requirements in (1) above, it must enter into an agreement with the U.S. Department of the Treasury
424B5
TRML
Tourmaline Bio Inc
24 Jan 24
Prospectus supplement for primary offering
9:20pm
, it must enter into an agreement with the U.S. Department of the Treasury requiring, among other things, that it undertake to identify accounts held
8-K
EX-99.1
kn13xh1c077dddcr6
24 Jan 24
Results of Operations and Financial Condition
5:10pm
8-K
EX-10.1
q445 rcpca
27 Oct 23
Departure of Directors or Certain Officers
5:17pm
8-K
EX-10.7
xqni6x8fktkx
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
8-K
EX-10.10
ad3nh9efawoyy3
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
424B3
pijlmkdlsy2
15 Sep 23
Prospectus supplement
6:31am
425
q20lii
13 Sep 23
Business combination disclosure
9:14am
8-K
EX-99.1
f2a27t96ky9 idf2
13 Sep 23
Regulation FD Disclosure
9:13am
S-4/A
rfh799fg9ntylmt
25 Aug 23
Registration of securities issued in business combination transactions (amended)
4:34pm
S-4
1l47eg msvma5
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
S-4
EX-10.6
087q3z1l
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
425
lafm6uvk9r
22 Jun 23
Business combination disclosure
9:12am